Metabolic fingerprint of insulin resistance in human polymorphonuclear leucocytes

Autores de IIS La Fe
Participantes ajenos a IIS La Fe
- Palomino-Schatzlein, M
- Simo, R
- Hernandez, C
- Ciudin, A
- Mateos-Gregorio, P
- Hernandez-Mijares, A
- Herance, JR
Grupos
Abstract
The present study was aimed at determining the metabolic profile of PMNs in obese subjects, and to explore its potential relationship with insulin resistance (IR). To achieve this goal, a pilot clinical study was performed using PMNs from 17 patients with obesity and IR, and 17 lean controls without IR, which was validated in an additional smaller cohort (consisting of 10 patients and 10 controls). PMNs were isolated from peripheral blood and nuclear magnetic resonance was used to perform the metabolomic analysis. A total of 48 metabolites were quantified. The main metabolic change found in PMNs was a significant increase in 2-aminoisobutyric acid with a direct correlation with HOMA-IR (p<0.001), BMI (p<0.000001) and waist circumference (p<0.000001). By contrast, a decrease of 3-hydroxyisovalerate was observed with an inverse correlation with HOMA-IR (p = 0.001), BMI (p = 0.001) and waist circumference (p = 0.0001). Notably, the metabolic profile in plasma was different than that obtained in PMNs. In summary, our results suggest that the change in 3-hydroxyisovalerate and 2-aminoisobutyric is the key metabolic fingerprint in PMNs of obese subjects with IR. In addition, our methodology could be an easy and reliable tool for monitoring the effect of treatments in the setting of precision medicine.
Datos de la publicación
- ISSN/ISSNe:
- 1932-6203, 1932-6203
- Tipo:
- Article
- Páginas:
- -
- PubMed:
- 30005063
- Factor de Impacto:
- 1,100 SCImago ℠
- Cuartil:
- Q1 SCImago ℠
Plos One PUBLIC LIBRARY SCIENCE
Citas Recibidas en Web of Science: 8
Documentos
- No hay documentos
Filiaciones
Keywords
- CHAIN AMINO-ACIDS; ADIPONECTIN; OBESITY; PLASMA
Proyectos y Estudios Clínicos
UNA APROXIMACIÓN ÓMICA AL DIAGNÓSTICO DE LA TUBERCULOSIS
PCIN-2013-041 . MINISTERIO DE ECONOMIA Y COMPETITIVIDAD; FUNDACIÓN PARA LA INVESTIGACIÓN DEL HOSPITAL UNIVERSITARIO LA FE DE LA COMUNIDAD VALENCIANA . 2015
HERRAMIENTAS DE RMN PARA EL DESARROLLO DE UNA PLATAFORMA PARA LA IDENTIFICACIÓN DE DIANAS, LA EVALUACIÓN DE FÁRMACOS Y LA PERSONALIZACIÓN DE TRATAMIENTOS BASADA EN APROXIMACIONES METABOLÓMICAS
Investigador Principal: ANTONIO PINEDA LUCENA
SAF2014-53977-R . MINISTERIO DE ECONOMIA Y COMPETITIVIDAD . 2015
RECALL. DESARROLLO DE PROTOTIPOS QUÍMICOS ORIENTADOS A LA GENERACIÓN DE TERAPIAS AVANZADAS PARA EL TRATAMIENTO DE LA ENFERMEDAD DE ALZHEIMER
Investigador Principal: ANTONIO PINEDA LUCENA
RTC-2016-4803-1 . MINISTERIO DE ECONOMIA Y COMPETITIVIDAD . 2016
Plataforma de Innovación en Tecnologías Médicas y Sanitarias - ITEMAS
Investigador Principal: SILVIA SÁNCHEZ SALVO
PT17/0005/0011 . INSTITUTO DE SALUD CARLOS III . 2018
Identificación de biotipos moleculares de cáncer de próstata como base de una medicina de precisón (BIOChiP).
Investigador Principal: LÓPEZ
PROMETEO/2016/103 . 2016
Cita
Palomino M,Simo R,Hernandez C,Ciudin A,Mateos P,Hernandez A,PINEDA A,Herance JR. Metabolic fingerprint of insulin resistance in human polymorphonuclear leucocytes. PLoS One. 2018. 13. (7):e0199351. IF:2,776. (2).